DennisHLangerMDJD
Psychiatry • Naples, FLBoard of Directors/Founder, Biopharmaceutical Companies.; Board of Directors, Quoin Pharmaceuticals (Nasdaq:QNRX); Braeburn, Inc.; Board of Directors, Whitehead Institute for Biomedical Research; former Senior Vice President, Research and Development, GlaxoSmithKline; former Clinical Professor, Psychiatry, Georgetown University School of Medicine.
Dr. Langer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8231 Bay Colony Dr
#1804
Naples, FL 34108
Summary
- Dennis Langer, MD, is a Psychiatry specialist located in Naples, FL, with a subspecialty in Child & Adolescent Psychiatry. He completed his medical education at Georgetown University School of Medicine in 1975, followed by an internship and residency at Yale-New Haven Medical Center. Dr. Langer also pursued fellowships in Child and Adolescent Psychiatry at National Capital Consortium and Boston Children’s Hospital. Additionally, he holds a J.D. cum laude from Harvard Law School. He served as Senior Vice President of Research and Development at GlaxoSmithKline from 1994 to 2004. Dr. Langer has several publications, notably on psychopharmacology, in well-regarded journals like Neurology and The American Journal of Medicine.
Education & Training
Harvard Law SchoolJ.D., Law, cum laude, 1980 - 1983
Boston Children’s HospitalFellowship, Child and Adolescent Psychiatry, 1980 - 1982
National Capital ConsortiumFellowship, Child and Adolescent Psychiatry, 1978 - 1980
Yale-New Haven Medical CenterResidency, Psychiatry, 1976 - 1978- Yale-New Haven Medical CenterInternship, Internal Medicine, 1975 - 1976
Georgetown University School of MedicineClass of 1975- Columbia UniversityBA, Biology, 1969 - 1971
Certifications & Licensure
FL State Medical License 2009 - 2026
PA State Medical License 1992 - 2026
NJ State Medical License 1994 - 2025
IL State Medical License 1985 - 2017
MD State Medical License 1978 - 1982
American Board of Psychiatry and Neurology Psychiatry
Publications & Presentations
PubMed
- 149 citationsValproic acid hepatic fatalities. II. US experience since 1984.Fritz E. Dreifuss, Dennis H. Langer, Karen A. Moline, Jim E. Maxwell
Neurology. 1989-02-01 - 66 citationsSide effects of valproate.Fritz E. Dreifuss, Dennis H. Langer
The American Journal of Medicine. 1988-01-25 - 72 citationsHepatic Considerations in the Use of Antiepileptic DrugsFritz E. Dreifuss, Dennis H. Langer
Epilepsia. 1987-08-01
Committees
- Board of Directors, Whitehead Institute for Biomedical Research 2020 - Present
- Member, Dean's Advisory Board, Harvard Law School 2010 - Present
- Member, Committee on Medical Center Affairs, Board of Directors, Georgetown University 2007 - 2012
- Chair, Committee on Medical Center Affairs, Board of Regents, Georgetown University 2006 - 2010
- Vice Chair, Board of Visitors, Columbia College 2005 - 2008
Industry Relationships
- Director, Creyon Bio, Inc.2021 - Present
- Director, Empirico, Inc.2021 - Present
- Director, Quoin Pharmaceuticals, Inc. (Nasdaq:QNRX)2021 - Present
- Board of Directors, Braeburn, Inc.2015 - Present
- Vice Chair, Board of Directors, EnGene, Inc.2015 - 2023
- Board of Directors, Myriad Genetics, Inc. (Nasdaq:MYGN)2004 - 2022
- Board of Directors, Dicerna Pharmaceuticals, Inc. (Nasdaq:DRNA)2007 - 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
